2020
DOI: 10.1016/j.isci.2020.101158
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Myoglobin Delivery as a Strategy for Enhancing the Sensitivity of Hypoxic Cancer Cells to Radiation

Abstract: The N-terminal domain of Cry3Aa can be used to generate sub-micron particles Genetic fusion of functional peptides to protein particles targets them to A549 cells Myoglobin is an effective oxygen carrier for delivery of O 2 into hypoxic cancer cellsTargeted myoglobin delivery to hypoxic cancer cells increased their radiosensitivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
1

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 53 publications
0
19
1
Order By: Relevance
“…Collectively, Mb might assume positive roles in slowing cancer progression. Most recently, targeted delivery of O 2 -bound myoglobin was suggested to be an effective approach to enhance the efficacy of radiotherapy via increasing intracellular oxygen levels [ 201 ].…”
Section: Myoglobinmentioning
confidence: 99%
“…Collectively, Mb might assume positive roles in slowing cancer progression. Most recently, targeted delivery of O 2 -bound myoglobin was suggested to be an effective approach to enhance the efficacy of radiotherapy via increasing intracellular oxygen levels [ 201 ].…”
Section: Myoglobinmentioning
confidence: 99%
“…Michael K. Chan’s group has provided the most comprehensive investigation to date on this aspect. They published [ 45 , 91 , 92 , 93 , 94 , 95 ] and patented [ 96 , 97 , 98 ] a strategy involving different Cry toxins and more specifically Cry3Aa, which they selected for further investigations for several reasons. Cry3Aa is a toxin with high self-assembly propensity that is able to crystallize both in vitro and in vivo with similar crystal packing interfaces, indicating that its crystallization process is strongly driven by the toxin itself, pending an adequate toxin concentration [ 31 , 99 , 100 ].…”
Section: Functionalizing Toxin Crystals For the Development Of New Biotechnological Toolsmentioning
confidence: 99%
“…The same group also explored the potential of Cry3Aa crystals for drug delivery [ 91 , 94 , 95 ]. The use of crystalline formulations for the storage and delivery of biopharmaceutical proteins has received increasing interest during the last decade [ 13 , 103 , 104 ] as it offers many advantages associated with their higher stability, long-lasting and progressive diffusion within the organism, and long-term storage [ 3 , 4 ].…”
Section: Functionalizing Toxin Crystals For the Development Of New Biotechnological Toolsmentioning
confidence: 99%
See 1 more Smart Citation
“…To obtain a high affinity and specific binder to GPC-3, the tumor-targeting peptide with the advantage of synthesis and modification is an alternative to other than traditional antibodies (11,12). Recently, phage-displayed libraries containing numerous randomized peptides on the surface of phages are becoming more popular for screening a specific binder to the selected target.…”
Section: Introductionmentioning
confidence: 99%